Medical genetics questions test more than the ability to name a condition. You may need to interpret a pedigree, calculate recurrence risk, distinguish a screening result from a diagnosis, or decide what a genetic result can—and cannot—tell you. The eight single-best-answer questions below practise those skills. They are subject questions, not a representation of any one exam’s format.

For each question, choose the best answer before reading the explanation displayed beneath it. Pay attention to the reasoning: in genetics, a small change in the family relationship or the type of test can change the answer.

1. Recognising an autosomal dominant pattern

This question tests transmission risk when one parent is heterozygous for an autosomal dominant condition.

Question 11 mark

A man with a pathogenic heterozygous variant causing an autosomal dominant condition has a child with a woman who does not carry the variant. Assuming complete penetrance, what is the probability that each child inherits the variant?

The affected parent is heterozygous, so each gamete has a 1 in 2 chance of carrying the variant. Each pregnancy is an independent event, giving a 50% chance for each child. The 25% option is a common distractor from autosomal recessive recurrence calculations; it does not apply to this cross.

The risk is calculated separately for each pregnancy; the outcome of one pregnancy does not alter the probability for the next. The assumption of complete penetrance matters: inheritance of a variant and development of the associated phenotype are not always equivalent.

2. Calculating autosomal recessive recurrence risk

This question tests the standard recurrence risk when both parents carry a pathogenic variant in the same autosomal recessive gene.

Question 21 mark

A couple has one child with an autosomal recessive condition caused by pathogenic variants in both copies of a gene. Both parents are confirmed carriers. What is the probability that their next child will also be affected?

For two carrier parents, each pregnancy has a 1 in 4 chance of inheriting both pathogenic alleles, a 1 in 2 chance of being a carrier, and a 1 in 4 chance of inheriting neither. The strongest distractor is 50%, which is the probability of being a carrier, not the probability of being affected.

Keep the three outcomes distinct: affected, unaffected carrier, and unaffected non-carrier. The chance of an affected child remains 25% for each pregnancy, regardless of the couple’s previous children.

3. Applying X-linked recessive inheritance

This question tests how to calculate risk for a son when his mother carries an X-linked recessive variant.

Question 31 mark

A woman is a confirmed carrier of a pathogenic variant causing an X-linked recessive condition. The biological father does not have the condition. What is the probability that each of her sons will inherit the variant?

A son receives his X chromosome from his mother. A carrier mother has a 1 in 2 chance of passing on the X chromosome carrying the variant, so each son has a 50% chance of inheriting it. The 25% distractor would be the chance of an affected child when the sex of the child is not specified, under the usual assumptions.

The question specifies sons, so do not multiply the 50% transmission risk by the chance of a child being male. If asked about all pregnancies rather than sons, clarify whether the requested risk is for inheriting the variant or for being an affected child.

4. Estimating carrier frequency from prevalence

This question tests an approximate Hardy–Weinberg calculation for a rare autosomal recessive condition.

Question 41 mark

In a population assumed to be in Hardy–Weinberg equilibrium, the prevalence of an autosomal recessive condition is 1 in 10,000. Assuming the condition is rare, what is the approximate carrier frequency?

For an autosomal recessive condition, affected prevalence is q². If q² is 1/10,000, q is about 1/100. Carrier frequency is 2pq, which is approximately 2q when the allele is rare: about 2/100, or 1 in 50. The 1 in 100 distractor is the approximate frequency of the disease allele, not carriers.

The useful approximation is carrier frequency ≈ 2√(prevalence) for a rare condition under the stated assumptions. Real populations may not meet those assumptions; ancestry, consanguinity and population structure can affect an individual’s risk.

5. Interpreting a variant of uncertain significance

This question tests the clinical limits of a result that has not been classified as pathogenic or benign.

Question 51 mark

A patient’s genetic test identifies a variant of uncertain significance in a gene associated with the suspected condition. Which is the most appropriate interpretation?

A variant of uncertain significance (VUS) has insufficient evidence for classification as pathogenic or benign. It should not, on its own, determine clinical management or be used for predictive testing of relatives. The strongest distractor is treating it as pathogenic: uncertainty does not establish disease causation.

Clinical decisions should use the patient’s presentation, family history and other relevant evidence, not the VUS as if it were a confirmed cause. Additional evidence, including segregation information, may contribute to later reclassification through appropriate clinical processes.

6. Determining whether two variants are in trans

This question tests phase: whether two variants in a recessive gene lie on opposite copies of the gene or on the same copy.

Question 61 mark

A patient with a suspected autosomal recessive condition has two different pathogenic variants reported in the same gene, each detected as heterozygous. What additional information is needed to establish whether they can explain the condition?

For a typical autosomal recessive diagnosis, pathogenic variants must affect both copies of the gene. If the two variants are in trans, each copy carries one; if they are in cis, both may be on the same copy, leaving the other unaffected. The strongest distractor is exon location: two variants in one exon can still be in trans, and variants in different exons can be in cis.

Family testing can help establish phase if the relevant relatives are available: for example, whether each variant was inherited from a different parent. The laboratory or genetics team can advise on the appropriate approach for the specific result.

7. Understanding a prenatal screening result

This question tests the distinction between a screening result and a diagnostic result.

Question 71 mark

A pregnant patient receives a high-probability result from cell-free DNA screening for a fetal chromosomal condition. What is the most appropriate next step to establish whether the fetus is affected?

Cell-free DNA testing is a screening test, not a definitive fetal diagnosis. A high-probability result should prompt appropriate counselling and discussion of diagnostic testing, such as a sample obtained through chorionic villus sampling or amniocentesis where clinically appropriate. The strongest distractor is treating the screen as diagnostic; a screening result estimates risk and needs interpretation in context.

The choice and timing of diagnostic testing depend on the clinical situation and local care pathways. Do not infer a diagnosis from a screening result alone; direct the patient to qualified prenatal genetics care for individual advice.

8. Interpreting a low variant allele fraction

This question tests a possible explanation for a variant detected at a lower-than-expected fraction in a blood sample.

Question 81 mark

Sequencing of a blood sample identifies a pathogenic variant at a variant allele fraction of 12%. The condition is usually caused by a heterozygous variant. Which possibility should be considered?

A lower-than-expected variant allele fraction can be consistent with mosaicism, in which a variant is present in a proportion of cells. It is not proof of mosaicism: technical factors and sample-specific issues also need consideration, and further investigation may be appropriate. The strongest distractor is assuming a sequencing error; the fraction alone cannot establish that.

Variant allele fraction is a measurement in a particular sample, not a direct count of all affected cells throughout the body. Interpretation depends on the assay, the gene and the clinical context; a genetics professional or laboratory may recommend confirmation or testing of another tissue.

Review the themes you missed

After answering, group errors by skill rather than memorising which option was correct. A useful review screen might rank variant interpretation and inheritance calculations by the proportion of marks earned, then show how often each topic has come up in your own practice.

Where marks go missing
58%Variant interpretation8×
67%Inheritance and recurrence risk10×
81%Screening and diagnostic testing5×

If the same distinction costs you marks more than once, turn it into a focused revision prompt. For example, practise explaining why a VUS is not equivalent to a pathogenic result, then test yourself again on a different case.

Remediation tray

You lost this mark twice: two heterozygous pathogenic variants are reported in a recessive gene. What must you establish about their phase before concluding that both gene copies are affected?

Add cardDismiss

How MySummaries helps

Build a medical genetics board from your own course notes, then generate questions and flashcards from the material you need to revise. Use MySummaries to revisit weak topics and practise explaining the reasoning behind each answer.